Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Payables (2024 - 2025)

Carlsmed's Payables history spans 2 years, with the latest figure at $4.5 million for Q4 2025.

  • For Q4 2025, Payables rose 85.78% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $4.5 million, up 85.78%, while the annual FY2025 figure was $4.5 million, 85.78% up from the prior year.
  • Payables reached $4.5 million in Q4 2025 per CARL's latest filing, up from $2.7 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $4.5 million in Q4 2025 to a low of $2.4 million in Q4 2024.